A subgroup of the human papillomaviruses (HPVs) are known to cause cancers of the uterine cervix and other genital areas, the so-called "high risk" HPVs.
The Cervista test is used to diagnose the presence of DNA from the "high-risk" HPVs in cervical samples.
The sample for the test is taken in the same way that a Pap smear test is performed.
There are two Cervista tests available, Cervista HPV 16/18, which identified the two HPV types most likely to cause cancer, and Cervista HPV HR, which identifies all "high-risk" HPV types.
Cervista testing is not recommended for routine screening; rather, it is used in combination with physical examination, medical history, and other testing to help make decisions about management and follow-up on a case-by-case basis.
The Cervista test is used to diagnose the presence of DNA from the "high-risk" HPVs in cervical samples.
The sample for the test is taken in the same way that a Pap smear test is performed.
There are two Cervista tests available, Cervista HPV 16/18, which identified the two HPV types most likely to cause cancer, and Cervista HPV HR, which identifies all "high-risk" HPV types.
Cervista testing is not recommended for routine screening; rather, it is used in combination with physical examination, medical history, and other testing to help make decisions about management and follow-up on a case-by-case basis.
No comments:
Post a Comment